JPH08325158A - Viral disease-preventing and treating agent and feed - Google Patents

Viral disease-preventing and treating agent and feed

Info

Publication number
JPH08325158A
JPH08325158A JP7128149A JP12814995A JPH08325158A JP H08325158 A JPH08325158 A JP H08325158A JP 7128149 A JP7128149 A JP 7128149A JP 12814995 A JP12814995 A JP 12814995A JP H08325158 A JPH08325158 A JP H08325158A
Authority
JP
Japan
Prior art keywords
feed
rhodopseudomonas
therapeutic agent
preventive
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7128149A
Other languages
Japanese (ja)
Inventor
Tadakazu Tamai
忠和 玉井
Hiroshi Nakajima
中島  浩
Koji Oda
浩司 織田
Nobuyuki Sato
信行 佐藤
Takeshi Okada
剛 岡田
Hikari Kimura
光 木村
Takao Ando
孝雄 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruha Corp
Original Assignee
Maruha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruha Corp filed Critical Maruha Corp
Priority to JP7128149A priority Critical patent/JPH08325158A/en
Publication of JPH08325158A publication Critical patent/JPH08325158A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To obtain a viral disease-preventing and -treating agent and feed which is effective against viral diseases of Pisces and Crustacea and shows safety and excellent efficacy that it can be used instead of an antibiotic agent. CONSTITUTION: This Pisces and Crustacea viral diseases-preventive and therapeutic agent contains, as an active ingredient, the cells bodies of a bacterium having antiviral activity in Rhodopseudomonas or Acetobacter such as Rhodopseudomonas capsulata, Rhodopseudomonas sphaeroides or Acetobacter aceti. These bacteria are cultured, for example, in a medium enriched with carbohydrates, alcohol or organic acids, at a pH of 4.0-9.5 at 20-40 deg.C for 12 hours to 5 days. The culture mixture is transferred to centrifugal tubes, centrifuged at 10,000rpm for 10 minutes to obtain the cells as a precipitate. The therapeutic agent or feed contains the dried cell bodies and the dose is preferably 1-300mg/kg/day in 2-3 portions.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、魚類、甲殻類のウイル
ス病予防治療剤及び飼料に関する。
FIELD OF THE INVENTION The present invention relates to a preventive / therapeutic agent for viral diseases of fish and crustaceans and feed.

【0002】[0002]

【従来の技術】養魚技術は近年急速な発展を遂げ、養殖
面積(経営体数)は年々増加している。しかし、天然の
魚類、甲殻類と違い、養殖の場合は高密度で飼育されて
いる為に、病気にかかるものも多い。特に病原性のウイ
ルスによる被害は甚大である。例えば、1992年の台湾で
のエビの大量へい死が、翌年、韓国、中国、及び日本に
伝播し、エビ養殖業に大きな被害をもたらした。これら
はバキュロウイルス感染エビがビブリオ症に二次感染し
たためだと考えられている。
2. Description of the Related Art The fish farming technology has made rapid progress in recent years, and the aquaculture area (the number of management bodies) is increasing year by year. However, unlike natural fish and crustaceans, many of them are sick because they are raised at a high density in aquaculture. The damage caused by pathogenic viruses is particularly great. For example, the mass mortality of shrimp in Taiwan in 1992 spread to South Korea, China, and Japan the following year, causing great damage to the shrimp aquaculture industry. It is believed that these are due to the secondary infection of baculovirus-infected shrimp with vibriopathies.

【0003】従来より、魚類、甲殻類の伝染性疾患に対
しては、抗生物質が使用されてきたが、耐性菌の発生
や、動物体内での残留の問題が起こり、使用が制限され
ている。これらの病気のうち細菌病に対しては抗生物質
に代わるものとして、細菌成分が著効を示すことが見い
だされ、安全性の高い予防治療薬として開発されている
が、ウイルス病に対しては抗生物質に代わる有効な薬剤
は知られていない。
Conventionally, antibiotics have been used for infectious diseases of fish and crustaceans, but their use is limited due to the generation of resistant bacteria and the problem of residual in the animal body. . Of these diseases, bacterial components have been found to be highly effective as an alternative to antibiotics for bacterial diseases, and have been developed as highly safe preventive and therapeutic agents, but for viral diseases There are no known effective drugs to replace antibiotics.

【0004】細菌の細胞壁成分は免疫賦活剤(アジュバ
ンド)として古くから知られており、免疫増強活性が検
討されている。しかしながら、魚類や無脊椎動物である
甲殻類の免疫機構は、哺乳動物と異なっている上に、細
菌とウイルスでは感染増殖の機構が全く異なっているの
で、細菌に対する予防治療薬がウイルスに対して効果を
示すとは一般に考えられていない。
The cell wall component of bacteria has long been known as an immunostimulant (adjuvant), and its immunopotentiating activity has been investigated. However, the immune system of fish and invertebrate crustaceans is different from that of mammals, and the mechanism of infection / proliferation is completely different between bacteria and viruses. It is not generally considered to be effective.

【0005】また、最近、バチラス(Bacillus) 属、ブ
レビバクテリウム(Brevibacterium)属、コリネバクテリ
ウム(Corynebacterium) 属、エセリシア(Escherichia)
属、ラクトバチルス(Lactobacillus) 属、ストレプトコ
ッカス(Streptococcus) 属、ストレプトミセス(Strepto
myces)属、またはビフィドバクテリウム(Bifidobacteri
um) 属に属する細菌の菌体の殺菌処理物、該細菌の機械
的破砕処理物、若しくは酵素分解処理を行うことによっ
て得られる細胞破砕物及びこの細胞破砕物を分画して得
られる細胞壁成分含有物のうち、少なくとも一つを飼料
に配合することを特徴とする魚類、甲殻類のウイルス病
予防治療剤が報じられている(特開平6-181656 号公報)
。しかしながら、ロドシュードモナス(Rhodopseudomo
nas)属、またはアセトバクター(Acetobacter)属に属
する細菌を魚類、甲殻類のウイルス感染症に対する予防
治療剤として利用することを言及したものはない。
Recently, the genus Bacillus, the genus Brevibacterium, the genus Corynebacterium, the genus Escherichia.
Genus, Lactobacillus genus, Streptococcus genus, Streptomyces
genus myces, or Bifidobacteri
um) sterilized product of bacterial cells of genus bacteria, mechanical crushed product of the bacterium, cell crushed product obtained by performing enzymatic decomposition treatment, and cell wall component obtained by fractionating this crushed product A preventive / therapeutic agent for viral diseases of fish and crustaceans, characterized in that at least one of the contained substances is added to the feed, has been reported (JP-A-6-181656).
. However, Rhodopseudomo
There is no mention of using bacteria belonging to the genus nas) or the genus Acetobacter as a preventive / therapeutic agent for viral infections of fish and crustaceans.

【0006】[0006]

【発明が解決しようとする課題】本発明の課題は、抗生
物質に代わり得る安全で優れた効果を有する魚類、甲殻
類のウイルス病予防治療剤ならびに飼料を提供すること
にある。
An object of the present invention is to provide a preventive / therapeutic agent for viral diseases of fish and crustaceans, which has a safe and excellent effect and can substitute for antibiotics, and a feed.

【0007】[0007]

【課題を解決するための手段】本発明者等は、上記課題
を解決すべく鋭意研究を重ねた結果、ロドシュードモナ
ス(Rhodopseudomonas)属、またはアセトバクター(Ac
etobacter)属に属する細菌が、魚類、甲殻類のウイルス
病に有効であることを見いだし、本発明を完成するに至
った。
Means for Solving the Problems As a result of intensive research to solve the above problems, the present inventors have found that the genus Rhodopseudomonas or the acetobacter (Ac
The inventors have found that bacteria belonging to the genus etobacter) are effective against viral diseases of fish and crustaceans, and have completed the present invention.

【0008】即ち、本発明はロドシュードモナス(Rhod
opseudomonas)属、またはアセトバクター(Acetobacte
r)属に属し、抗ウイルス感染活性を有する細菌の菌体を
有効成分とする魚類、甲殻類のウイルス病予防治療剤、
ならびに該細菌の菌体を含有する魚類、甲殻類用飼料で
ある。以下、本発明を詳細に説明する。
That is, the present invention relates to Rhod
genus opseudomonas, or Acetobacter (Acetobacte)
r) a fish, a crustacean viral disease preventive / therapeutic agent which belongs to the genus and contains bacterial cells of bacteria having antiviral infection activity as an active ingredient,
And a feed for fish and crustaceans containing the bacterial cells of the bacterium. Hereinafter, the present invention will be described in detail.

【0009】本発明において、予防ないし治療の対象と
なる魚類としては、ブリ、タイ、ウナギ、コイ、ニジマ
ス、アユ、ギンザケ、シマアジ、ティラピア、ヒラメ、
トラフグ、フナ等を挙げることができる。また、甲殻類
としては、クルマエビ、ブラックタイガー、大正エビ、
ホワイトシュリンプ等が挙げられる。本発明のウイルス
病予防治療剤の有効成分は、ロドシュードモナス(Rhodo
pseudomonas)属、またはアセトバクター(Acetobacter)
属に属する細菌、具体的にはロドシュードモナス・カプ
シュラタ(Rhodopseudomonas capsulata)、ロドシュード
モナス・スファエロイド(Rhodopseudomonas sphaeroid
es)、ロドシュードモナス・パルストリス(Rhodopseudo
monas palustris)、ロドシュードモナス・ビリディス(R
hodopseudomonas viridis)、ロドシュードモナス・アシ
ドフィリア(Rhodopseudomonas acidophilia)、ロドシュ
ードモナス・ゲラチノーサ(Rhodopseudomonas gelatino
sa) 、アセトバクター・アセチ(Acetobacter aceti) 、
アセトバクター・リキュエファシエンス(Acetobacter l
iquefaciens)、アセトバクター・パステウリアヌス(Ace
tobacter pasteurianus)である。
In the present invention, fishes to be prevented or treated include yellowtail, thailand, eel, carp, rainbow trout, sweetfish, coho salmon, striped horse mackerel, tilapia, flounder,
Examples include troughs and crucian carp. In addition, as shellfish, prawns, black tiger, Taisho shrimp,
Examples include white shrimp. The active ingredient of the preventive / therapeutic agent for viral diseases according to the present invention is Rhodopseudomonas.
pseudomonas) or Acetobacter
Bacteria belonging to the genus, specifically Rhodopseudomonas capsulata, Rhodopseudomonas sphaeroid
es), Rhodopseudo
monas palustris), Rhodes pseudomonas viridis (R
hodopseudomonas viridis), Rhodopseudomonas acidophilia, Rhodopseudomonas gelatino
sa), Acetobacter aceti,
Acetobacter liquefaciens
iquefaciens), Acetobacter pasteurianus (Ace
tobacter pasteurianus).

【0010】上記の細菌の培養には、通常これらの細菌
が資化しうる栄養源であれば何でも使用し得る。例え
ば、グルコース、シュクロース等の炭水化物、エタノー
ル、グリセロール等のアルコール、酢酸、プロピオン酸
等の有機酸、大豆油等、又はこれらの混合物の炭素源、
酵母エキス、ペプトン、肉エキス、コーンスティープリ
カー、硫安、アンモニア等の含窒素無機、有機栄養源、
リン酸塩、マグネシウム、チアミン等のビタミン類を適
宜配合した通常の培地が用いられる。
For the culture of the above-mentioned bacteria, any nutrient source which can normally be utilized by these bacteria can be used. For example, glucose, carbohydrates such as sucrose, alcohols such as ethanol and glycerol, organic acids such as acetic acid and propionic acid, soybean oil and the like, or a carbon source of a mixture thereof,
Yeast extract, peptone, meat extract, corn steep liquor, ammonium sulfate, nitrogen-containing inorganic and organic nutrients such as ammonia,
An ordinary medium in which vitamins such as phosphate, magnesium and thiamine are appropriately mixed is used.

【0011】培養の方法としては、例えば栄養培地のp
Hを4.0 〜9.5 の範囲とし、20〜40℃で12時間〜5 日間
培養すればよい。培養後、培養液を遠沈管に移し、10,0
00r.p.m.にて10分間遠心分離することで沈殿した菌体を
得る。上記で得られた菌体を凍結乾燥し、粉砕した後に
適量のトウモロコシデンプン、タルク及びステアリン酸
マグネシウム等とともに充分混和し、常法により粒度を
調整することにより製剤化する。製剤中の菌体含有量は
特に限定はされないが、飼料へ添加するときは飼料へ均
一に混合できる含有量であればよく、また散剤から造粒
する時は、魚類や甲殻類の種類により、またその成長ス
テージに合わせて調整すればよい。
As a culture method, for example, p.
Culturing may be carried out at 20 to 40 ° C for 12 hours to 5 days with H in the range of 4.0 to 9.5. After culturing, transfer the culture medium to a centrifuge tube and
Precipitated cells are obtained by centrifugation at 00 rpm for 10 minutes. The microbial cells obtained above are freeze-dried, pulverized, and then thoroughly mixed with an appropriate amount of corn starch, talc, magnesium stearate, etc., and the particle size is adjusted by a conventional method to prepare a formulation. The bacterial cell content in the formulation is not particularly limited, but when added to the feed, it may be a content that can be uniformly mixed in the feed, and when granulating from a powder, depending on the type of fish or crustacean, It may be adjusted according to the growth stage.

【0012】一方、飼料を調製するには、通常養殖用に
用いられる飼料原料を、対象とする水産動物に応じて適
宜選択、配合し、これに上記の菌体を添加、配合、湿潤
すればよい。飼料原料としては、一般的には魚粉、エビ
ミール、イカミール、小麦粉、コーングルテン、ビール
酵母、コレステロール、ビタミン、ミネラルが用いられ
る。飼料に上記菌体を添加、配合、湿潤する際には、全
飼料中0.01〜3 重量%となるようにすればよい。
On the other hand, in order to prepare the feed, if the feed raw material usually used for aquaculture is appropriately selected and blended according to the target aquatic animal, and the above-mentioned bacterial cells are added, blended and moistened. Good. As feed ingredients, fish meal, shrimp meal, squid meal, wheat flour, corn gluten, brewer's yeast, cholesterol, vitamins and minerals are generally used. When the above-mentioned microbial cells are added to, mixed with and moistened in the feed, the content may be 0.01 to 3% by weight in the total feed.

【0013】本発明のウイルス病予防治療剤、ならびに
それを含有する飼料によって、治療ないし予防されうる
ウイルス(病)としては、ヒラメではヒラメラブドウイ
ルス(HRV) 、トラフグでは口白症ウイルス、ニジマスで
は伝染性膵臓壊死症ウイルス(IPNV), ウイルス性出血性
敗血症(VHS),伝染性造血器壊死症ウイルス(IHNV)、コ
イでは春ウイルス病(SVC), 鰾炎症(SBI) 、ナマズでは
ウイルス病(CCVD)、サケではヘルペスウイルス, Pike
(カワカマス)稚魚のウイルス病、クルマエビではRod
shapaed virus-Penaeus japonicus (RV-PJ) 、多くの海
水および淡水魚に感染するリンホシスチス病ウイルス等
が挙げられるが、これらに限定されない。
As the virus (disease) that can be treated or prevented by the preventive and / or therapeutic agent for viral diseases of the present invention, and the feed containing the same, floramelad virus (HRV) is used in flounder, stolon virus is used in trough, and rainbow trout is used in rainbow trout. Infectious pancreatic necrosis virus (IPNV), viral hemorrhagic septicemia (VHS), infectious hematopoietic necrosis virus (IHNV), spring virus disease (SVC) in carp, fin inflammation (SBI), viral disease in catfish ( CCVD), herpes virus in salmon, Pike
(Pike) Viral disease of juvenile, Rod in prawn
Examples include, but are not limited to, shapaed virus-Penaeus japonicus (RV-PJ), and lymphocystis disease virus that infects many seawater and freshwater fish.

【0014】本発明にいうウイルス病予防治療剤とは、
上記のウイルス病の感染および発病の予防あるいは発病
したものを治療するものをいう。本発明のウイルス病予
防治療剤又は飼料の投与量、投与時期は適用する魚類、
甲殻類の種類、ウイルス病の種類により適宜変更しうる
が、例えば乾燥した菌体として1 〜300mg/kg体重を1日
に2〜3回に分けて与えればよい。また、本発明のウイ
ルス病予防治療剤又は飼料を稚魚期に与えておけば予防
的効果が得られる。
The viral disease preventive / therapeutic agent according to the present invention is
It refers to the prevention of the infection and the onset of the above viral diseases, or the treatment of the onset. The dose of the preventive / therapeutic agent for viral diseases or the feed of the present invention, the administration time is the fish to be applied,
Although it may be appropriately changed depending on the type of crustacean and the type of viral disease, for example, 1 to 300 mg / kg body weight of dried cells may be given in 2 to 3 divided doses per day. In addition, a preventive effect can be obtained by giving the preventive / therapeutic agent for viral diseases or the feed of the present invention during the juvenile stage.

【0015】[0015]

【実施例】以下、実施例を挙げて本発明を更に詳細に説
明するが、これらの実施例は本発明の範囲を何等限定す
るものではない。 〔実施例1〕 ウイルス予防治療剤の調製 (1) 菌体の取得 ポリペプトン(日水製薬)10g 、酵母エキス(オリエン
タル酵母)6g、NaCl 5g 、MgSO4・7H2O 2g 、寒天(Difc
o)10gを900ml の蒸留水に溶解した後、1N NaOHを用いて
pH 7.0に調節した。培地を蒸留水にて1Lにフィルアップ
した後、124℃で20分間オートクレーブして滅菌した。
滅菌後、60℃前後まで冷やした培地を浅型シャーレに蒔
いて寒天培地を作成した。
The present invention will be described in more detail below with reference to examples, but these examples do not limit the scope of the present invention. Example 1 Preparation of viral prophylactic therapeutic agent (1) obtaining polypeptone bacteria (Nissui Pharmaceutical) 10 g, yeast extract (Oriental Yeast) 6g, NaCl 5g, MgSO 4 · 7H 2 O 2g, agar (DIFC
o) Dissolve 10 g in 900 ml distilled water and then use 1N NaOH.
The pH was adjusted to 7.0. The medium was filled up to 1 L with distilled water and then sterilized by autoclaving at 124 ° C for 20 minutes.
After sterilization, the medium cooled to about 60 ° C. was sown on a shallow dish to prepare an agar medium.

【0016】上記培地に、ロドシュードモナス・カプシ
ュラタ(Rhodopseudomonas capsulata) (ATCC 11166) 、
ロドシュードモナス・スファエロイド(Rhodopseudomon
as sphaeroides)(ATCC 17023)、或いはアセトバクター
・アセチ(Acetobacter aceti)(ATCC 15973) を静置培養
または液体培養にて30℃で5 日間培養し、培養液を遠沈
管に移し、10,000r.p.m.にて10分間遠心し、その沈殿物
を凍結乾燥し、粉砕した菌体を得た。
In the above medium, Rhodopseudomonas capsulata (ATCC 11166),
Rhodopseudomon
as sphaeroides) (ATCC 17023) or Acetobacter aceti (ATCC 15973) by static or liquid culture at 30 ° C for 5 days, transfer the culture medium to a centrifuge tube, and spin at 10,000 rpm. After centrifugation for 10 minutes, the precipitate was freeze-dried to obtain crushed cells.

【0017】(2) 製剤化 (1)で得られた菌体200mg 、トウモロコシデンプン150mg
、タルク80mg及びステアリン酸マグネシウム30mgを充
分混和し、60メッシュの金網を通過させて粒度を調整
し、本発明のウイルス病予防治療剤を得た。
(2) 200 mg of the bacterial cell obtained in the formulation (1), 150 mg of corn starch
, Talc (80 mg) and magnesium stearate (30 mg) were thoroughly mixed and passed through a 60-mesh wire net to adjust the particle size to obtain the viral disease preventive / therapeutic agent of the present invention.

【0018】〔実施例2〕 養殖エビ用飼料の調製 (その1)クルマエビ用基礎飼料(林兼産業株式会社
製)に上記実施例1(1) で得られた菌体を3重量%添加
した。得られた配合物を90℃以上で5 分間蒸すことでグ
ルテンを変性させて要求される保型性を付与し、その
後、80℃で8 時間熱風乾燥し、ペレットマシーンを用い
てペレット状(2mm φ×5mm)に成形し、クルマエビ用飼
料を得た。
Example 2 Preparation of Cultured Shrimp Feed (Part 1) 3 wt% of the bacterial cells obtained in Example 1 (1) above was added to a basic prawn for prawns (made by Hayashikane Sangyo Co., Ltd.). The resulting formulation is steamed at 90 ° C or above for 5 minutes to modify the gluten and impart the required shape retention property, then dried at 80 ° C for 8 hours with hot air and pelletized (2 mm) using a pellet machine. (φ x 5 mm) to obtain feed for prawns.

【0019】(その2)クルマエビ用ドライペレット基
礎飼料(林兼産業株式会社製)100gを、上記実施例1
(1) の途中で得られる菌体の懸濁液(106個/ml)100ml に
30分間浸した後、30℃にて3 時間乾燥することで、生菌
を含んだ飼料を作成した。
(Part 2) 100 g of dry pellet basic feed (made by Hayashikane Sangyo Co., Ltd.) for prawns was used in Example 1 above.
In the process of (1), add 100 ml of cell suspension (10 6 cells / ml).
After soaking for 30 minutes, it was dried at 30 ° C for 3 hours to prepare a feed containing live bacteria.

【0020】〔実施例3〕 養殖魚飼料の調製(1) 市販のトラフグ用飼料基礎粉末〔大洋飼料(株)社製〕
に、上記実施例1(1)で得られた菌体を3重量%添加し
た。得られた配合物をペレットマシーンを用いて成形(5
mmφ×10mm) して、40℃にて5 時間乾燥してトラフグ用
ドライペレットを得た。
[Example 3] Preparation of cultured fish feed (1) Commercially available feed basic powder for troughs [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of the bacterial cells obtained in Example 1 (1) above was added to. Mold the resulting blend using a pellet machine (5
mmφ × 10 mm) and dried at 40 ° C. for 5 hours to obtain dry pellets for trough.

【0021】〔実施例4〕 養殖魚飼料の調製(2) 市販のマス稚魚用飼料基礎粉末〔大洋飼料(株)社製〕
に、上記実施例1(1)で得られた菌体を3重量%添加し
た。得られた配合物をペレットマシーンを用いて成形(2
mmφ×10mm) して、40℃にて5 時間乾燥してマス稚魚用
ドライペレットを得た。
Example 4 Preparation of Cultured Fish Feed (2) Commercially available feed powder for trout fry [manufactured by Taiyo Feed Co., Ltd.]
3% by weight of the bacterial cells obtained in Example 1 (1) above was added to. Mold the resulting compound using a pellet machine (2
mmφ × 10 mm) and dried at 40 ° C. for 5 hours to obtain dry pellets for trout fry.

【0022】〔実施例5〕 養殖魚飼料の調製(3) 市販のヒラメ用ドライペレット飼料基礎粉末〔大洋飼料
(株)社製、5mm φ×5mm 〕100gに、上記実施例1(1)
の途中で得られる菌体の懸濁液(106個/ml)100ml を噴霧
した後、30℃にて3 時間乾燥することで、ヒラメ用生菌
を含んだ飼料を作成した。
Example 5 Preparation of Cultured Fish Feed (3) In 100 g of commercially available dry pellet feed basic powder for flounder [manufactured by Taiyo Feed Co., Ltd., 5 mm φ × 5 mm] 100 g of the above Example 1 (1)
100 ml of a suspension of cells (10 6 cells / ml) obtained during the process was sprayed and then dried at 30 ° C for 3 hours to prepare a feed containing live flounder.

【0023】〔試験例1〕 エビRod shaped virus-Pen
aeus japonicus (RV-PJ)ウイルスに対する感染予防効果 RV-PJに感染してへい死したクルマエビの中腸腺周辺を
摘出し、10倍量の緩衝液を加えてホモジナイズした抽出
液をポアサイズ0.4 μmのフィルターでろ過したものを
健常なエビの腹部筋中に注入すると、甲皮の白斑等の本
感染症特有の症状を伴ってへい死する。さらに、電子顕
微鏡観察によって、本感染症はバキュロウイルスに属す
ると思われるウイルスによって引き起こされることがわ
かった。
[Test Example 1] Shrimp Rod shaped virus-Pen
Preventive effect against aeus japonicus (RV-PJ) virus Infection around the midgut gland of the tiger prawn, which died due to infection with RV-PJ, was excised, and the extract homogenized with 10 volumes of buffer was added to a 0.4 μm pore size filter. When the product filtered in step (2) is injected into the abdominal muscles of healthy shrimp, it dies with the symptoms peculiar to this infection, such as vitiligo on the instep. Furthermore, electron microscopic observation revealed that this infection was caused by a virus that seems to belong to the baculovirus.

【0024】健常なクルマエビ(平均体重22g)に1 日2
回、上記実施例2で得られた養殖エビ用飼料を1 日当た
り体重の1%与えた。14日目に10尾のクルマエビに、上記
と同様にして得られたウイルス液を80倍希釈したものを
100μl ずつ、あるいはコントロールとして緩衝液を注
入し、その後の生残率を調べた。結果を表1に示す。
[0024] 2 times a day for healthy prawns (average weight 22g)
The feed for cultured shrimp obtained in Example 2 above was given 1% of the body weight per day. On the 14th day, 10 viral prawns were diluted 80 times with the virus solution obtained in the same manner as above.
100 μl each or a buffer was injected as a control, and the survival rate after that was examined. The results are shown in Table 1.

【0025】[0025]

【表1】 [Table 1]

【0026】健常なエビにRV-PJ ウイルスを感染させる
と、7 日後にはへい死率が6 割となるが、本発明のRhod
opseudomonas capsulata添加飼料を与えることにより、
7日目のへい死率を2 割に、またRhodopseudomonas sph
aeroides、Acetobacter aceti 添加飼料ではいずれもへ
い死率を3 割にくい止めることができた。尚、ウイルス
を感染させないエビは試験期間中全くへい死しなかっ
た。
When healthy shrimp were infected with the RV-PJ virus, the mortality rate was 60% after 7 days, but the Rhod of the present invention was used.
By feeding opseudomonas capsulata supplemented feed,
The mortality rate on the 7th day was reduced to 20%, and Rhodopseudomonas sph
Both diets containing aeroides and Acetobacter aceti were able to reduce the mortality rate by 30%. The shrimp that did not infect the virus did not die at all during the test period.

【0027】〔試験例2〕 トラフグ(Takifugu rubrip
es) を用いた口白症ウイルスに対する感染予防効果 健常なトラフグ(平均体重50g)に上記実施例3で得られ
たトラフグ用飼料を1日当たり体重の10% 与えた。14日
目に10尾のトラフグに1 ×103.7TCID50/mlの力価の口白
症ウイルス液を0.1ml ずつ背部の皮下に接種し、その後
の生存率を調べた。結果を表2に示す。
[Test Example 2] Takifugu rubrip
es) for preventing infection of the oral disease by healthy oral troughfish (average body weight 50 g) was fed with the feed for the troughfish obtained in Example 3 above at 10% of the body weight per day. On day 14, ten troughs were inoculated subcutaneously on the dorsal part with 0.1 ml each of 1 × 10 3.7 TCID 50 / ml titer of the virus of oral disease, and the survival rate was examined thereafter. Table 2 shows the results.

【0028】[0028]

【表2】 [Table 2]

【0029】健常なトラフグに口白症ウイルスを感染さ
せると、7 日後にはへい死率が8 割となるが、本発明の
Rhodopseudomonas capsulata添加飼料を与えることによ
り、7 日目のへい死率を1 割に、またRhodopseudomonas
sphaeroides、Acetobacteraceti 添加飼料ではいずれ
もへい死率を3 割にくい止めることができた。尚、ウイ
ルスを感染させないトラフグ(ブランク)のへい死は1
割であった。
[0029] Infection of healthy troughfish with the disease of white-cold disease causes a death rate of 80% after 7 days.
Feeding Rhodopseudomonas capsulata-supplemented feed reduced the mortality rate on day 7 to 10%.
Both sphaeroides and Acetobacter aceti-supplemented mortality could be suppressed to less than 30%. It should be noted that the death of the tiger puffer (blank) that does not infect the virus is 1
It was a percentage.

【0030】〔試験例3〕 ニジマス(Salmo gairdner
i) を用いた伝染性膵臓壊死症ウイルス(IPNV)に対する
感染予防効果 健常なニジマス(平均体重4g) に上記実施例4で得られ
たニジマス用飼料を1日当たり体重の20% 与えた。14日
目に10尾のニジマスに5 ×104.8TCID50/mlの力価のIPNV
液を50μl ずつ静脈投与した。結果を表3に示す。
Test Example 3 Rainbow Trout (Salmo gairdner)
Infection preventive effect against infectious pancreatic necrosis virus (IPNV) using i) Healthy rainbow trout (average weight 4 g) was fed with the rainbow trout feed obtained in Example 4 above at 20% of the body weight per day. IPNV with a titer of 5 × 10 4.8 TCID 50 / ml on 10 rainbow trouts on day 14
The liquid was intravenously administered at 50 μl each. The results are shown in Table 3.

【0031】[0031]

【表3】 [Table 3]

【0032】健常なニジマスにIPNVを感染させると、10
日後にはへい死率が8 割となるが、本発明のRhodopseud
omonas capsulata添加飼料を与えることにより、10日目
のへい死率を1 割に、またRhodopseudomonas sphaeroid
es、Acetobacter aceti 添加飼料ではいずれもへい死率
を3 割にくい止めることができた。尚、ウイルスを感染
させないニジマス(ブランク)は試験期間中全くへい死
しなかった。
When a healthy rainbow trout was infected with IPNV, 10
The mortality rate is 80% after a day, but the Rhodopseud of the present invention
By feeding omonas capsulata-supplemented feed, the mortality rate on the 10th day was reduced to 10%, and Rhodopseudomonas sphaeroid
The es and Acetobacter aceti-added feeds were able to reduce the mortality rate to 30% or less. In addition, the rainbow trout (blank) that was not infected with the virus did not die at all during the test period.

【0033】〔試験例4〕 ヒラメ(Paralichthys oliv
aceus)ラブドウイルス(HRV) に対する予防効果 実施例5で得られたヒラメ用生菌添加飼料をヒラメに与
え、HRV に対する予防効果を調べた。健常なヒラメ(平
均体重80g)に上記実施例5で得られたニジマス用飼料を
1 日当たり体重の5%を2回に分けて与えた。14日目に10
尾のヒラメに5×106.8TCID50/mlの力価のHRV 液を0.1ml
ずつ静脈投与した。結果を表4に示す。
Test Example 4 Flounder (Paralichthys oliv)
Aceus) Rhabdovirus (HRV) Preventive Effect The flounder supplemented with the live flounder supplemented feed obtained in Example 5 was fed to flounder to examine the preventive effect against HRV. A healthy flounder (average weight 80 g) was fed with the rainbow trout feed obtained in Example 5 above.
5% of body weight per day was given in two divided doses. 10 on day 14
0.1 ml of HRV solution with a titer of 5 × 10 6.8 TCID 50 / ml was added to the tail flounder.
Each was administered intravenously. The results are shown in Table 4.

【0034】[0034]

【表4】 [Table 4]

【0035】健常なヒラメにHRV を感染させると、14日
後にはへい死率が4 割となるが、本発明のRhodopseudom
onas capsulata添加飼料を与えることにより、14日目の
へい死率を1 割に、またRhodopseudomonas sphaeroide
s、Acetobacter aceti 添加飼料ではいずれもへい死率
を2 割にくい止めることができた。尚、ウイルスを感染
させないヒラメ(ブランク)は試験期間中全くへい死し
なかった。
When healthy flounder is infected with HRV, the mortality rate is 40% after 14 days, but the Rhodopseudom of the present invention
By feeding onas capsulata supplemented feed, the mortality rate on the 14th day was 10%, and Rhodopseudomonas sphaeroide
The mortality rate of s and Acetobacter aceti-containing feeds could be suppressed to 20% or less. The flounder (blank) that was not infected with the virus did not die at all during the test period.

【0036】〔試験例5〕 毒性試験 ICR 系マウスの雌雄マウスに上記3種の菌体を表5に示
した量、単回投与した。対照群として、雄には0.7ml 、
雌には0.6ml の精製水をそれぞれ同様に投与した。結果
を表5に示す。
[Test Example 5] Toxicity test A single dose of the above-mentioned three types of bacterial cells was administered to male and female ICR mice. As a control group, 0.7 ml for males,
Females were similarly dosed with 0.6 ml of purified water. The results are shown in Table 5.

【0037】[0037]

【表5】 [Table 5]

【0038】表5に示したように、上記3種の菌体にお
ける毒性試験ではいずれも試験動物に異常および死亡例
は認められず、検体のマウスにおける単回経口投与によ
る致死量は雌雄とも2,000 mg/kg 以上にあると認められ
た。
As shown in Table 5, no abnormalities or deaths were observed in the test animals in any of the toxicity tests with the above-mentioned three types of bacterial cells, and the lethal dose of a single oral administration of the test substance in mice was 2,000 in both males and females. It was confirmed to be above mg / kg.

【0039】[0039]

【発明の効果】本発明によれば、魚類、甲殻類のウイル
ス病に有効で安全な予防治療剤ならびに飼料が提供され
る。
INDUSTRIAL APPLICABILITY According to the present invention, a prophylactic / therapeutic agent and a feed which are effective and safe against viral diseases of fish and shellfish are provided.

フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:01) (C12N 1/20 C12R 1:02) (72)発明者 佐藤 信行 茨城県つくば市和台16−2 マルハ株式会 社中央研究所内 (72)発明者 岡田 剛 茨城県つくば市和台16−2 マルハ株式会 社中央研究所内 (72)発明者 木村 光 京都府京都市下京区若宮通り六条上る81 (72)発明者 安藤 孝雄 兵庫県尼崎市塚口町1丁目22番地の1− 110号Continuation of front page (51) Int.Cl. 6 Identification number Reference number within the agency FI Technical display location C12R 1:01) (C12N 1/20 C12R 1:02) (72) Inventor Nobuyuki Sato Wadai, Tsukuba, Ibaraki 16-2 Central Research Institute of Maruha Co., Ltd. (72) Inventor Tsuyoshi Okada Wadai, Tsukuba, Ibaraki Prefecture 16-2 Central Research Institute of Maruha Co., Ltd. (72) Hikari Kimura Rokujo Wakamiya-dori, Shimogyo-ku, Kyoto 81 (72) Inventor Takao Ando 1-122, 1-22 Tsukaguchi-cho, Amagasaki-shi, Hyogo

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 ロドシュードモナス(Rhodopseudomona
s)属、またはアセトバクター(Acetobacter)属に属
し、抗ウイルス感染活性を有する細菌の菌体を有効成分
とする魚類、甲殻類のウイルス病予防治療剤。
1. Rhodopseudomona
s) or a preventive and remedy for viral diseases of fish and crustaceans, which comprises bacterial cells of the genus Acetobacter and has antiviral infection activity as an active ingredient.
【請求項2】 ロドシュードモナス(Rhodopseudomona
s)属、またはアセトバクター(Acetobacter)属に属
し、抗ウイルス感染活性を有する細菌の菌体を含有する
魚類、甲殻類用飼料。
2. Rhodopseudomona
s) A feed for fishes and crustaceans, which contains bacterial cells of a bacterium belonging to the genus or the genus Acetobacter and having antiviral infection activity.
JP7128149A 1995-05-26 1995-05-26 Viral disease-preventing and treating agent and feed Pending JPH08325158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7128149A JPH08325158A (en) 1995-05-26 1995-05-26 Viral disease-preventing and treating agent and feed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7128149A JPH08325158A (en) 1995-05-26 1995-05-26 Viral disease-preventing and treating agent and feed

Publications (1)

Publication Number Publication Date
JPH08325158A true JPH08325158A (en) 1996-12-10

Family

ID=14977606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7128149A Pending JPH08325158A (en) 1995-05-26 1995-05-26 Viral disease-preventing and treating agent and feed

Country Status (1)

Country Link
JP (1) JPH08325158A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042204A1 (en) * 1997-03-21 1998-10-01 Kabushiki Kaisha Yakult Honsha Infectious disease preventive/remedy for fishes and shellfishes
EP1797169A4 (en) * 2004-10-08 2008-11-19 Coho Hydroclean Sa A method of cultivating animals to develop a desired color and to increase their rate of growth

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042204A1 (en) * 1997-03-21 1998-10-01 Kabushiki Kaisha Yakult Honsha Infectious disease preventive/remedy for fishes and shellfishes
EP1797169A4 (en) * 2004-10-08 2008-11-19 Coho Hydroclean Sa A method of cultivating animals to develop a desired color and to increase their rate of growth

Similar Documents

Publication Publication Date Title
Gatlin III Nutrition and fish health
EP2348880B1 (en) Method for using a bacillus subtilis strain to enhance animal health
Montero-Rocha et al. Immunostimulation of white shrimp (Litopenaeus vannamei) following dietary administration of Ergosan
US20220184159A1 (en) Method of boosting innate immunity
Okey et al. The use of synbiotics (Prebiotic and probiotic) in aquaculture development
Farooqi et al. Immunostimulants for aquaculture health management
KR20010071331A (en) Additives for crustacean or fish feeds and feeds
JP4331824B2 (en) Infectious disease prevention and treatment for seafood
CN1093578A (en) The prevention of fish and Crustaceans virosis and therapeutic agent and feedstuff
CN109452490A (en) A kind of prevention and treatment the chicken ventriculitis as caused by mycotoxicosis, the feed addictive of proventriculitis and its application
JPH08325158A (en) Viral disease-preventing and treating agent and feed
KR102389326B1 (en) Composition for prevention, treatment or improvement of gastric disorders containing Corynebacterium strain and its culture thereof
JP3649787B2 (en) Prophylactic agent for enterococcal infection in fish and use thereof
JPH04193832A (en) Preventive and treating agent of microbism in fishes and crustacea
FR2472389A1 (en) ANTIBIOTIC COMPOSITIONS CONTAINING MACROLIDE AND AMINOHETEROSIDE
JP2001008636A (en) Feed composition for preventing infectious disease
JPH1160495A (en) Medicine for preventing disease for immune system immature animal
JPWO2004084922A1 (en) Infection protective agent for seafood
JP2923263B2 (en) Feed composition for fish culture
US11337441B2 (en) Probiotic composition for use in a feed additive
CN105764520B (en) Method for inhibiting infectious disease of crustacean
JP2008285431A (en) Composition for preventing and treating viral infectious disease of cultured fish
WO2023018691A1 (en) Methods and compositions for aquaculture
JPH06217712A (en) Feed for crustacean
JP2001342140A (en) Medicine and feed for fish and crustacean

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051129

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061017

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070227